Healthcare -
Biotechnology - NASDAQ - US
$ 1.15
-4.17 %
$ 34.6 M
Market Cap
-0.67
P/E
ANTX - REVENUE
Revenue ANTX - AN2 Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR